NCT04715178

Brief Summary

This is an observational data registry study of pediatric cancer patients at participating Beat Childhood Cancer Consortium sites involving specimen banking and data collection.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
69mo left

Started Feb 2021

Longer than P75 for all trials

Geographic Reach
1 country

18 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Feb 2021Jan 2032

First Submitted

Initial submission to the registry

January 15, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 20, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

February 2, 2021

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2031

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2032

Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

9.9 years

First QC Date

January 15, 2021

Last Update Submit

January 30, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Create a data registry of clinical and molecular/genomic data

    Create a data registry of clinical and molecular/genomic data from cancer patients who have undergone biopsy or surgical resection for clinical care to better understand the relationship between genomic and molecular information and clinical outcomes.

    10 Years

  • Determine number and types of genomic alterations within tumor types/subtypes

    Define genomic landscape of pediatric cancers through the determination of the number and types of genomic alterations within tumor types/subtypes, across tumor types, and tumor evolution over time.

    10 Years

  • Evaluate the rate of actionable genomic alternations

    Evaluate the rate of actionable genomic alternations resulting in associated targeted therapies relative to all actionable genomic alterations.

    10 Years

  • Evaluate the correlation of baseline genomic alterations with clinical outcome.

    Evaluate the correlation of baseline genomic alterations with clinical outcome.

    10 Years

  • Identify biomarkers that predict risk of adverse outcomes that occur following pediatric cancer therapy.

    Identify biomarkers that predict risk of adverse outcomes that occur following pediatric cancer therapy.

    10 Years

Secondary Outcomes (4)

  • Bank additional specimens available for future research projects

    10 Years

  • Develop cell line and xenograft models of pediatric cancers for future research

    10 Years

  • Identify biomarkers that predict risks of disease states in subject controls that did not receive cancer therapy.

    10 Years

  • Identify biomarkers that may predict risk of disease dependent on sex, race, ethnicity, or the presence of comorbidities.

    10 Years

Study Arms (1)

Patients with suspected or confirmed pediatric solid tumors

Patients with suspected or confirmed pediatric solid tumors

Other: No intervention- registry only

Interventions

No intervention- registry only

Patients with suspected or confirmed pediatric solid tumors

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pediatric cancer subjects, survivorship, and healthy volunteers at The Pennsylvania State University and participating Beat Childhood Cancer Research Consortium sites.

You may qualify if:

  • No age restrictions
  • Subjects that fit into one of the following categories:
  • Subjects with suspected or confirmed cancers of childhood, adolescence, or young adulthood.
  • Survivors of a cancer of childhood, adolescence, or young adulthood (\> 6 months off last therapy for cancer)
  • Subjects with a disease-matched condition
  • Healthy volunteers- including any participants with medical conditions that are not disease-matched.
  • Written informed consent in accordance with institutional and FDA guidelines must be obtained from all subjects (or subjects' legal representative).

You may not qualify if:

  • Subject or his/her legally authorized representative (where applicable) did not consent for specimen banking and data collection for this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (18)

Arkansas Children's Hospital

Little Rock, Arkansas, 72202, United States

RECRUITING

Rady Children's Hospital

San Diego, California, 92123, United States

RECRUITING

Connecticut Children's Hospital

Hartford, Connecticut, 06106, United States

RECRUITING

Nicklaus Children's Miami

Miami, Florida, 33155, United States

RECRUITING

Arnold Palmer Hospital for Children

Orlando, Florida, 32806, United States

RECRUITING

St. Joseph's Children's Hospital

Tampa, Florida, 33614, United States

RECRUITING

University of Iowa

Iowa City, Iowa, 52242, United States

RECRUITING

Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine

Louisville, Kentucky, 40292, United States

RECRUITING

Children's Hospital and Clinics of Minnesota

Minneapolis, Minnesota, 55404, United States

RECRUITING

Children's Mercy Hospitals and Clinics

Kansas City, Missouri, 64108, United States

RECRUITING

Cardinal Glennon Children's Hospital

St Louis, Missouri, 63104, United States

RECRUITING

Levine Children's Hospital

Charlotte, North Carolina, 28204, United States

COMPLETED

AH Wake Forest Baptist - Brenner Children's Hospital

Winston-Salem, North Carolina, 27157, United States

RECRUITING

Randall Children's Hospital

Portland, Oregon, 97227, United States

RECRUITING

Penn State Milton S. Hershey Medical Center and Children's Hospital

Hershey, Pennsylvania, 17033, United States

RECRUITING

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

RECRUITING

Dell Children's Blood and Cancer Center

Austin, Texas, 78723, United States

RECRUITING

Children's Hospital of The King's Daughters

Norfolk, Virginia, 23507, United States

RECRUITING

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

whole blood, serum, urine, bone marrow, CSF, bucal swabs, tissue

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Giselle Sholler, MD

    Beat Childhood Cancer

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Beat Childhood Cancer Chair

Study Record Dates

First Submitted

January 15, 2021

First Posted

January 20, 2021

Study Start

February 2, 2021

Primary Completion (Estimated)

January 1, 2031

Study Completion (Estimated)

January 1, 2032

Last Updated

February 3, 2026

Record last verified: 2026-01

Locations